| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.008 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |